Months after developing one of the nation’s first saliva-based coronavirus tests, researchers at Rutgers University are closing in on their next breakthrough: A saliva test for both COVID-19 and the flu. The research is being conducted at RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — the same lab that gained federal approval in April for a coronavirus saliva test. The test allows people to collect their own samples at home and send them to be processed. Andrew Brooks, chief operating officer and director of technology development at RUCDR, said the lab hopes to have a test approved by the fall. And just in time for flu season. To read the full story.
Home / News / Rutgers researchers eye new saliva test breakthrough: A potential coronavirus and flu combo
Recent Posts
- Most residents don’t know N.J. offers medical aid in dying, survey finds.
- Rutgers Researchers Revive Decades-Old Pregnancy Cohort with Modern Scientific Potential.
- Spring allergy season returns to NJ. How bad will it be?
- A $750 million effort to revolutionize cancer care in N.J. opens next month.
- New study raises alarm over Alzheimer’s blood tests.
Categories
- Community (2,218)
- Covid (985)
- CTO Events (6)
- News (2,829)
- Pilots (21)